Exactech gets US rights to Italian bone cement:
This article was originally published in Clinica
Exactech has secured exclusive US rights to market and distribute Cemex bone cement from Tecres, a Verona, Italy-based company. The one-step delivery product has been in use in Europe for 10 years and will be offered alongside Exactech's hip and knee implants. The surgical implantation bone cement market in the US is worth $100 million a year, according to Exactech, of Gainesville, Florida.
You may also be interested in...
Feature: Public Health England has revealed it is only a week away from approving a COVID-19 antibody test for distribution via Amazon. HBW Insight looks at the race to place the first, government-approved coronavirus home-test on the UK market.
As part of its efforts to preserve patient access to medicines amid the COVID-19 pandemic, Russia is planning to cap drug prices if increases of more than 30% are detected. It will also allow online sales of non-prescription drugs and may also tighten the rules on fake and substandard products.
This is an update of recommendations from the European Medicines Agency's Committee for Medicinal Products for Human Use on the authorization of new medicines in the European Union, and updates on EU marketing authorization changes recommended by the CHMP.